TrialHuman vaccines & immunotherapeutics2017

Safety and immunogenicity of GamEvac-Combi, a heterologous VSV- and Ad5-vectored Ebola vaccine: An open phase I/II trial in healthy adults in Russia.

I V Dolzhikova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.